Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Colorectal Neoplasms × Imiquimod × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Leukoplakia 1 Leukokeratosis, Hereditary Mucosal 1 Glioblastoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Cetuximab 39 pembrolizumab 31 Irinotecan 31 Capecitabine 31 Oxaliplatin 29 Bevacizumab 28 Fluorouracil 26 Leucovorin 24 Nivolumab 17 Gemcitabine 12 Cyclophosphamide 12 regorafenib 10 Folfox protocol 10 Pemetrexed 9 Cisplatin 9 Carboplatin 9 Paclitaxel 8 IFL protocol 8 tislelizumab 7 Panitumumab 7 130-nm albumin-bound paclitaxel 7 durvalumab 6 HMPL-013 6 Drug Therapy 6 irinotecan sucrosofate 5 Trifluridine 5 Specimen Handling 5 Ipilimumab 5 Interleukin-2 5 Docetaxel 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00785122 2013-05-16

IMA910-101

Immatics Biotechnologies GmbH

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡